Holdings of Fidelity Advisor Biotechnology Fund
Fidelity Advisor Series VII · Original filing · Compare with another fund · Report an error
- Net assets
- 1.9B $ including 1.8B $ in equities, 96.2 %
- Positions
- 70 in 6 countries
- Top ten
- 48.8 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AbbVie Inc | 1,335,480 | 282.2M $ | 14.83 % |
| 2 | Alnylam Pharmaceuticals Inc | 339,486 | 105.1M $ | 5.52 % |
| 3 | Gilead Sciences Inc | 788,900 | 103.2M $ | 5.42 % |
| 4 | Insmed Inc | 489,600 | 66.7M $ | 3.51 % |
| 5 | Cogent Biosciences Inc | 1,834,818 | 65.7M $ | 3.45 % |
| 6 | Dianthus Therapeutics Inc | 730,062 | 64.1M $ | 3.37 % |
| 7 | Spyre Therapeutics Inc | 851,772 | 63.4M $ | 3.33 % |
| 8 | Ascendis Pharma A/S | 269,225 | 61.8M $ | 3.24 % |
| 9 | Argenx SE | 77,200 | 60.3M $ | 3.17 % |
| 10 | Biogen Inc | 294,100 | 55.7M $ | 2.92 % |
| 11 | Oruka Therapeutics Inc | 737,386 | 50.4M $ | 2.65 % |
| 12 | Amgen Inc | 135,103 | 46.8M $ | 2.46 % |
| 13 | Vaxcyte Inc | 763,629 | 43.7M $ | 2.30 % |
| 14 | Revolution Medicines Inc | 299,500 | 43.2M $ | 2.27 % |
| 15 | Nuvalent Inc | 412,264 | 41.3M $ | 2.17 % |
| 16 | Amylyx Pharmaceuticals Inc | 2,433,200 | 38.9M $ | 2.05 % |
| 17 | Apogee Therapeutics Inc | 452,639 | 37.5M $ | 1.97 % |
| 18 | Moderna Inc | 640,800 | 29.4M $ | 1.55 % |
| 19 | Xenon Pharmaceuticals Inc | 456,458 | 25.6M $ | 1.34 % |
| 20 | Viridian Therapeutics Inc | 1,782,464 | 24M $ | 1.26 % |
| 21 | Kiniksa Pharmaceuticals International Plc | 417,600 | 22.5M $ | 1.18 % |
| 22 | Roivant Sciences Ltd | 776,700 | 22.2M $ | 1.16 % |
| 23 | JADE BIOSCIENCES INC | 894,343 | 21.8M $ | 1.15 % |
| 24 | Praxis Precision Medicines Inc | 67,900 | 21.6M $ | 1.14 % |
| 25 | Crinetics Pharmaceuticals Inc | 544,470 | 21.1M $ | 1.11 % |
| 26 | Cytokinetics Inc | 312,871 | 20M $ | 1.05 % |
| 27 | Structure Therapeutics Inc | 481,200 | 19.9M $ | 1.05 % |
| 28 | Kymera Therapeutics Inc | 231,700 | 18.8M $ | 0.99 % |
| 29 | Natera Inc | 89,400 | 18.4M $ | 0.97 % |
| 30 | UCB SA | 65,200 | 17.7M $ | 0.93 % |
| 31 | Newamsterdam Pharma Co NV | 586,400 | 16.7M $ | 0.88 % |
| 32 | Viking Therapeutics Inc | 450,187 | 14M $ | 0.74 % |
| 33 | Enliven Therapeutics Inc | 328,862 | 13.6M $ | 0.71 % |
| 34 | Relay Therapeutics Inc | 1,028,900 | 13.3M $ | 0.70 % |
| 35 | Tyra Biosciences Inc | 354,200 | 12.3M $ | 0.65 % |
| 36 | ZENAS BIOPHARMA INC | 610,924 | 11.8M $ | 0.62 % |
| 37 | Olema Pharmaceuticals Inc | 777,200 | 11.2M $ | 0.59 % |
| 38 | Celldex Therapeutics Inc | 340,152 | 11.2M $ | 0.59 % |
| 39 | Travere Therapeutics Inc | 253,600 | 10.7M $ | 0.56 % |
| 40 | CG oncology Inc | 157,700 | 10.5M $ | 0.55 % |
| 41 | Stoke Therapeutics Inc | 317,700 | 10.4M $ | 0.55 % |
| 42 | Annexon Inc | 1,661,500 | 9.8M $ | 0.51 % |
| 43 | Rhythm Pharmaceuticals Inc | 117,433 | 9.6M $ | 0.50 % |
| 44 | CytomX Therapeutics Inc | 2,229,051 | 9.4M $ | 0.49 % |
| 45 | Disc Medicine Inc | 142,322 | 9.4M $ | 0.49 % |
| 46 | MBX Biosciences Inc | 304,600 | 9.2M $ | 0.48 % |
| 47 | Mineralys Therapeutics Inc | 331,100 | 8.8M $ | 0.46 % |
| 48 | Tango Therapeutics Inc | 403,626 | 8.7M $ | 0.46 % |
| 49 | Dyne Therapeutics Inc | 482,000 | 8.5M $ | 0.44 % |
| 50 | Alumis Inc | 330,600 | 8.2M $ | 0.43 % |
| 51 | DAMORA THERAPEUTICS INC | 298,142 | 7.7M $ | 0.40 % |
| 52 | Axsome Therapeutics Inc | 35,800 | 7.4M $ | 0.39 % |
| 53 | MapLight Therapeutics Inc | 202,900 | 6.5M $ | 0.34 % |
| 54 | Neurogene Inc | 243,700 | 6.4M $ | 0.33 % |
| 55 | Upstream Bio Inc | 691,003 | 6.3M $ | 0.33 % |
| 56 | Taysha Gene Therapies Inc | 939,800 | 6M $ | 0.32 % |
| 57 | CRESCENT BIOPHARMA INC | 251,090 | 5.6M $ | 0.30 % |
| 58 | Definium Therapeutics Inc | 254,100 | 5.6M $ | 0.29 % |
| 59 | Scholar Rock Holding Corp | 118,168 | 5.5M $ | 0.29 % |
| 60 | X4 PHARMACEUTICALS INC | 1,341,800 | 5.5M $ | 0.29 % |
| 61 | Solid Biosciences Inc | 677,565 | 4.9M $ | 0.26 % |
| 62 | AVALO THERAPEUTICS INC | 358,300 | 4.8M $ | 0.25 % |
| 63 | Janux Therapeutics Inc | 320,385 | 4.6M $ | 0.24 % |
| 64 | Edgewise Therapeutics Inc | 144,500 | 4.5M $ | 0.24 % |
| 65 | uniQure NV | 223,500 | 4.5M $ | 0.23 % |
| 66 | Tenax Therapeutics Inc | 322,600 | 4.2M $ | 0.22 % |
| 67 | Inventiva SACA | 685,400 | 3.5M $ | 0.18 % |
| 68 | First Tracks Biotherapeutics Inc | 148,400 | 3.5M $ | 0.18 % |
| 69 | Tectonic Therapeutic Inc | 120,995 | 3.4M $ | 0.18 % |
| 70 | VeraDermics Inc | 7,400 | 732.6K $ | 0.04 % |
Sector breakdown
- Health care 42.9 %
- Unattributed 57.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 99.0 %
- EUR 1.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 91.5 %
- Netherlands 4.5 %
- Canada 1.7 %
- Bermuda 1.2 %
- Belgium 1.0 %
- France 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 62 | 1.7B $ | 91.48 % |
| 2 | Netherlands | 3 | 81.6M $ | 4.45 % |
| 3 | Canada | 2 | 31.1M $ | 1.70 % |
| 4 | Bermuda | 1 | 22.2M $ | 1.21 % |
| 5 | Belgium | 1 | 17.7M $ | 0.97 % |
| 6 | France | 1 | 3.5M $ | 0.19 % |
Cite this page
Titelia. "Holdings of Fidelity Advisor Biotechnology Fund". https://titelia.com/en/funds/S000005321